Funder: Dept. of the Army -- USAMRAA
Due Dates: June 24, 2026: Pre-Application (Preproposal) | August 13, 2026: Regulatory Application (if required) | September 30, 2026: Full Application | October 6, 2026: End of Application Verification Period
Funding Amounts: ~$5.6M total; up to $2.8M per award over 3 years; ~2 awards expected
Summary: Supports rapid implementation of phase 1 or small phase 2 clinical trials with high impact on ALS treatment or management.
Key Information: Pre-application required; community collaboration and regulatory strategy plan are mandatory.